News | March 11, 2023
Marksans Pharma announces USFDA approval for Famotidine Tablets
Marksans' OTC Famotidine Tablets USP are acid reducers
Marksans' OTC Famotidine Tablets USP are acid reducers
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Time to combine innovation, access and technology to deliver positive patient outcomes
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Subscribe To Our Newsletter & Stay Updated
